StreetInsider.com News Articles

Modular Medical secures U.S. pharmacy benefit manager deal

Fri, 04 Sep 2026 08:01:29 -0400

Modular Medical, Inc. (NASDAQ: MODD) has signed a contract with a national U.S. pharmacy benefit manager (PBM), making its Pivot tubeless patch pump available through the PBM's network, according to a company statement.

The San Diego-based medical device company did not identify the PBM by name, though Chief Executive Officer Jeb Besser described it as "one of the largest in the country."

"We believe this agreement with a national PBM represents an important commercialization milestone for our Pivot patch pump," Besser said. "PBMs play a critical role in enabling patient access to therapies and medical technologies."

The Pivot tubeless patch pump is a

Modular Medical Announces Contract with National U.S. Pharmacy Benefit Manager, Expanding Access to Pivot Tubeless Patch Pump

Fri, 04 Sep 2026 08:00:00 -0400

SAN DIEGO, CA / ACCESS Newswire / September 4, 2026 / Modular Medical, Inc. ("Modular Medical" or "the Company") (NASDAQ:MODD), a commercial-stage medical device company preparing for the commercial launch of its next-generation Pivot™ tubeless patch pump, today announced that it has secured a contract with a national U.S. pharmacy benefit manager (PBM) in the United States. Pursuant to the contract, the Company's Pivot insulin delivery system is now available through the national PBM. The Company believes the engagement with this national PBM represents a significant step forward in broadening patient access

Modular Medical Announces Contract with National U.S. Pharmacy Benefit Manager, Expanding Access to Pivot Tubeless Patch Pump

Fri, 04 Sep 2026 08:00:00 -0400

FDA clears software updates for Modular Medical's Pivot insulin pump

Thu, 03 Sep 2026 08:01:48 -0400

Modular Medical, Inc. (NASDAQ: MODD) announced that the U.S. Food and Drug Administration has cleared a set of software enhancements for its Pivot tubeless insulin patch pump system.

The clearance covers updates to bolus dosing functionality, including the ability for users to customize the amount of insulin delivered with each button press, along with an enhanced user interface and other software upgrades.

Chief Executive Officer Jeb Besser said the clearance was received ahead of the company's planned fourth-quarter 2026 commercial launch. "The cleared improvements represent the first in a series of enhancements and upgrades to the Pivot platform," Besser said in a

FDA clears software updates for Modular Medical's Pivot insulin pump

Thu, 03 Sep 2026 08:01:48 -0400

Modular Medical, Inc. (NASDAQ: MODD) announced that the U.S. Food and Drug Administration has cleared a set of software enhancements for its Pivot tubeless insulin patch pump system.

Modular Medical Announces FDA Clearance of Pivot Tubeless Insulin Patch Pump Enhancements

Thu, 03 Sep 2026 08:00:00 -0400

Clearance Covers Software Enhancements for Greater Patient Flexibility and Pivot Customization

SAN DIEGO, CA / ACCESS Newswire / September 3, 2026 / Modular Medical, Inc. ("Modular Medical" or "the Company") (NASDAQ:MODD), a commercial-stage medical device company preparing for the full commercial launch of its next-generation Pivot™ tubeless patch pump, today announced that the U.S. Food & Drug Administration (FDA) has cleared a set of software enhancements to its Pivot insulin delivery system, further expanding the system's functionality and providing users with greater flexibility and customization options in bolus dosing, an enhanced user-interface

Modular Medical Announces FDA Clearance of Pivot Tubeless Insulin Patch Pump Enhancements

Thu, 03 Sep 2026 08:00:00 -0400

Clearance Covers Software Enhancements for Greater Patient Flexibility and Pivot Customization

Registration is Now Open for Tribe Public's CEO Presentation and Q&A Webinar Event Titled ''The Road To Revenue: Modular Medical's Strategy For Launching Pivot'' Featuring Modular Medical CEO - Friday

Wed, 02 Sep 2026 08:30:00 -0400

Meet with Modular Medical CEO Jeb Besser.
Discover The Pivot tubeless patch pump, a simple, wearable insulin delivery platform designed to provide continuous subcutaneous insulin infusion with both basal and bolus insulin delivery over a three-day wear period.
Explore How the Pivot represents a differentiated solution for insulin-dependent adults still on multiple daily injections, representing a multi-billion-dollar market opportunity.
Register at PivotLaunch.TribePublic.com.

SAN DIEGO, CA / ACCESS Newswire / September 2, 2026 / Modular Medical, Inc. (NASDAQ:MODD) ("Modular Medical" or the "Company"), a commercial-stage medical device company preparing for the full commercial

Registration is Now Open for Tribe Public's CEO Presentation and Q&A Webinar Event Titled ''The Road To Revenue: Modular Medical's Strategy For Launching Pivot'' Featuring Modular Medical CEO - Friday

Wed, 02 Sep 2026 08:30:00 -0400

Meet with Modular Medical CEO Jeb Besser.
Discover The Pivot tubeless patch pump, a simple, wearable insulin delivery platform designed to provide continuous subcutaneous insulin infusion with both basal and bolus insulin delivery over a three-day wear period.
Explore How the Pivot represents a differentiated solution for insulin-dependent adults still on multiple daily injections, representing a multi-billion-dollar market opportunity.
Register at PivotLaunch.TribePublic.com.

Form EFFECT Modular Medical, Inc.

Wed, 19 Aug 2026 06:04:00 -0400

si-local-file:///var/storage/secattach/20260819/26946800.html

Form EFFECT Modular Medical, Inc.

Wed, 19 Aug 2026 06:04:00 -0400

si-local-file:///var/storage/secattach/20260819/26946800.html

Form 10-Q Modular Medical, Inc. For: Jun 30

Fri, 14 Aug 2026 17:26:00 -0400

si-local-file:///var/storage/secattach/20260814/26932901.html

Form 10-Q Modular Medical, Inc. For: Jun 30

Fri, 14 Aug 2026 17:26:00 -0400

si-local-file:///var/storage/secattach/20260814/26932901.html

Form SCHEDULE 13G/A Modular Medical, Inc. Filed by: Solas Capital Management, LLC

Fri, 14 Aug 2026 10:54:00 -0400

si-local-file:///var/storage/secattach/20260814/26926861.html

Form SCHEDULE 13G/A Modular Medical, Inc. Filed by: Solas Capital Management, LLC

Fri, 14 Aug 2026 10:54:00 -0400

si-local-file:///var/storage/secattach/20260814/26926861.html

Form SCHEDULE 13G Modular Medical, Inc. Filed by: Bleichroeder LP

Thu, 13 Aug 2026 16:17:00 -0400

si-local-file:///var/storage/secattach/20260813/26921401.html

Form SCHEDULE 13G Modular Medical, Inc. Filed by: Bleichroeder LP

Thu, 13 Aug 2026 16:17:00 -0400

si-local-file:///var/storage/secattach/20260813/26921401.html

Form SCHEDULE 13G Modular Medical, Inc. Filed by: Pathfinder Asset Management Ltd

Fri, 07 Aug 2026 15:40:00 -0400

si-local-file:///var/storage/secattach/20260807/26890679.html

Form SCHEDULE 13G Modular Medical, Inc. Filed by: Pathfinder Asset Management Ltd

Fri, 07 Aug 2026 15:40:00 -0400

si-local-file:///var/storage/secattach/20260807/26890679.html

Form S-3 Modular Medical, Inc.

Wed, 05 Aug 2026 16:01:00 -0400

si-local-file:///var/storage/secattach/20260805/26873586.html

Form S-3 Modular Medical, Inc.

Wed, 05 Aug 2026 16:01:00 -0400

si-local-file:///var/storage/secattach/20260805/26873586.html

Modular Medical to Participate in the Association of Diabetes Care & Education Specialists 2026 Annual Conference

Wed, 05 Aug 2026 08:45:00 -0400

SAN DIEGO, CA / ACCESS Newswire / August 5, 2026 / Modular Medical, Inc ("Modular Medical" or "the Company") (NASDAQ:MODD), a commercial-stage medical device company preparing for the full commercial launch of its next-generation Pivot™ tubeless patch pump, today announced that management will host a booth at the Association of Diabetes Care & Education Specialists 2026 Annual Conference (the "Conference") in Columbus, Ohio, from August 7-10, 2026, where they will showcase the new Pivot tubeless insulin patch pump.

Conference attendees will have the opportunity to experience live demonstrations of the tubeless Pivot insulin

Modular Medical to Participate in the Association of Diabetes Care & Education Specialists 2026 Annual Conference

Wed, 05 Aug 2026 08:45:00 -0400

Conference attendees will have the opportunity to experience live demonstrations of the tubeless Pivot insulin

Modular Medical plans five-city rollout of Pivot insulin pump in 2026

Mon, 03 Aug 2026 08:02:30 -0400

Modular Medical, Inc. (NASDAQ: MODD) announced plans to begin the first phase of commercialization of its Pivot tubeless patch pump across five U.S. markets in October 2026, according to a company press release.

The initial launch will cover Atlanta, Cincinnati/Lexington, Dallas, Houston, and Philadelphia. The company selected these markets following an analysis of national insurance claim, prescription, and market adoption data across more than 100 U.S. markets.

According to claims data from PurpleLab for the 24 months ended June 2025, the five markets collectively account for 14% of the nation's highest-volume insulin pump prescribers, 15% of all new insulin pump starts, and

Modular Medical Announces Launch of Pivot Insulin Delivery System Across Five Key U.S. Markets Beginning October 2026

Mon, 03 Aug 2026 08:00:00 -0400

First Phase of Strategic Rollout Targets Markets with Leading Insulin Pump Prescribers and Strong New Pump Adoption. Inizio will Provide Commercialization Expertise to Accelerate Awareness and Adoption of the Pivot Pump.

SAN DIEGO, CA / ACCESS Newswire / August 3, 2026 / Modular Medical, Inc ("Modular Medical" or "the Company") (NASDAQ:MODD), a commercial-stage medical device company preparing for the full commercial launch of its next-generation Pivot^™ tubeless patch pump, today announced plans to initiate the first phase of commercialization of its Pivot tubeless patch pump across five strategically selected U.S. markets beginning